Cargando…
Rational Design, Synthesis and Biological Evaluation of Novel Pyrazoline-Based Antiproliferative Agents in MCF-7 Cancer Cells
Breast cancer is a disease in which cells in the breast divide continuously without control. There are great limitations in cancer chemotherapy. Hence, it is essential to search for new cancer therapeutics. Herein, a novel series of EGFR/HER2 dual inhibitors has been designed based on the hybridizat...
Autores principales: | Fakhry, Mariam M., Mahmoud, Kazem, Nafie, Mohamed S., Noor, Ahmad O., Hareeri, Rawan H., Salama, Ismail, Kishk, Safaa M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9607164/ https://www.ncbi.nlm.nih.gov/pubmed/36297358 http://dx.doi.org/10.3390/ph15101245 |
Ejemplares similares
-
Design and Synthesis of Coumarin Derivatives as Cytotoxic Agents through PI3K/AKT Signaling Pathway Inhibition in HL60 and HepG2 Cancer Cells
por: Kishk, Safaa M., et al.
Publicado: (2022) -
Pyrazoles and Pyrazolines as Anti-Inflammatory Agents
por: Mantzanidou, Martha, et al.
Publicado: (2021) -
Design, Synthesis, and Biological Evaluation of Novel 3-Cyanopyridone/Pyrazoline Hybrids as Potential Apoptotic Antiproliferative Agents Targeting EGFR/BRAF(V600E) Inhibitory Pathways
por: Al-Wahaibi, Lamya H., et al.
Publicado: (2023) -
Pyrazoline derivatives as promising novel antischistosomal agents
por: Morais, Cristiane S., et al.
Publicado: (2021) -
Synthesis and biological evaluation of halogenated phenoxychalcones and their corresponding pyrazolines as cytotoxic agents in human breast cancer
por: Halim, Peter A., et al.
Publicado: (2021)